Tenon Medical, Inc. (NASDAQ:TNON) Stock Short Interest Report for October

Tenon Medical, Inc. (NASDAQ:TNON – Get Free Report) saw a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 94,671 shares, an increase of 82.8% from the October 15th total of 51,800 shares. Currently, 4.3% of the company’s stock are short sold. Based on an average daily trading volume, of 152,023 shares, the short-interest ratio is currently 0.6 days.

Tenon Medical Price Performance

NASDAQ:TNON opened at $1.41 on Monday. Tenon Medical has a 52 week low of $1.38 and a 52 week high of $43.05. The firm has a 50 day moving average of $3.00 and a 200 day moving average of $15.57. The stock has a market capitalization of $3.79 million, a price-to-earnings ratio of -0.04 and a beta of 1.43.

Tenon Medical (NASDAQ:TNON – Get Free Report) last announced its earnings results on Thursday, November 12th. The company reported ($5.39) earnings per share for the quarter, missing the consensus estimate of ($4.22) by ($1.17). Tenon Medical had a negative net margin of 305.10% and a negative return on equity of 907.60%. The firm had revenue of $1.43 million during the quarter, compared to analyst estimates of $1.55 million.

Insiders Place Their Bets

In other Tenon Medical news, major shareholder Financial Lp Hrt sold 65,582 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $5.56, for a total transaction of $364,635.92. Following the sale, the insider owned 15,839 shares of the company’s stock, valued at approximately $88,064.84. This trade represents a 80.55% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last ninety days, insiders acquired 129,945 shares of company stock worth $500,468 and sold 136,599 shares worth $605,467. 17.71% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

TNON has been the subject of a number of analyst reports. Wall Street Zen cut Tenon Medical from a “hold” rating to a “sell” rating in a research note on Saturday, October 31st. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tenon Medical in a research report on Thursday, October 15th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Tenon Medical has a consensus rating of “Hold”.

View Our Latest Research Report on Tenon Medical

Tenon Medical Company Profile

(Get Free Report)

Tenon Medical, Inc. (NASDAQ:TNON) is a medical device company focused on developing and commercializing technologies for the treatment of sacroiliac (SI) joint dysfunction. The SI joint connects the lower spine to the pelvis and can be a source of chronic lower-back and pelvic pain. The company’s primary product is the Catamaran SIJ Fusion System, a minimally invasive surgical system designed to stabilize and fuse the SI joint through a transfixation approach. The system uses a specialized implant and delivery instruments intended to support placement across the SI joint while addressing the underlying source of instability.

See Also

Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.